Weiss Multi-Strategy Advisers LLC - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 84 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2014. The put-call ratio across all filers is 2.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2015$158,000
-24.8%
10,000
-50.0%
0.01%
-14.3%
Q4 2014$210,000
+9.4%
20,0000.0%0.01%
+40.0%
Q3 2014$192,000
-11.9%
20,000
+5.8%
0.01%0.0%
Q2 2014$218,000
-41.1%
18,900
-48.9%
0.01%
-28.6%
Q1 2014$370,000
+105.6%
37,000
+168.3%
0.01%
+75.0%
Q4 2013$180,00013,7900.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q4 2014
NameSharesValueWeighting ↓
SV Health Investors, LLC 888,132$7,966,0006.12%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 1,054,678$9,460,0003.30%
Kassirer Asset Management Corp 363,700$3,262,0002.36%
WATER ISLAND CAPITAL LLC 3,359,140$30,131,0001.91%
Banco BTG Pactual S.A. 338,889$3,040,0001.43%
GARDNER LEWIS ASSET MANAGEMENT L P 1,941,012$17,411,0001.41%
FIRST NEW YORK SECURITIES LLC /NY 237,500$2,130,375,0001.41%
ALPINE ASSOCIATES MANAGEMENT INC. 3,804,600$34,089,0001.25%
Atika Capital Management LLC 300,000$2,691,0001.10%
Atika Capital Management LLC 298,200$2,672,0001.09%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders